BLCO Revenue third quarter 2026 Y/Y Growth Comment
Bausch and Lomb Corp reported Revenue growth of 7.34% year on year in the third quarter 2026, to $ 1,375.00 millions, this is lower than Bausch And Lomb Corp's recent average Revenue increase of 11.33%.
Looking into third quarter 2026 results within Medical Equipment & Supplies industry 128 other companies have achieved higher Revenue growth. While Bausch And Lomb Corp' s Revenue increase of 7.34% ranks overall at the positon no. 2387 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Bausch And Lomb's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
16.48 %
2.55 %
-11.46 %
(Dec 31 2023)
BLCO's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Bausch And Lomb Corp disclosed decrease in Revenue from the second quarter by -1.36% to $ 1,375.00 millions, from $ 1,394.00 millions achived in the previous reporting period.
Although periodic circumstance commonly energize III. Quarter 2026 Revenue, this plainly could not be substantial to rescue Medical Equipment & Supplies's company achievement, Most analysts pointed out.
Within Medical Equipment & Supplies industry 31 other companies have achieved higher Revenue quarter on quarter growth. While Bausch And Lomb's Revenue growth quarter on quarter, overall rank is 737.
In the III. Quarter 2026 Bausch And Lomb Corp disclosed decrease in Revenue from the second quarter by -1.36% to $ 1,375.00 millions, from $ 1,394.00 millions achived in the previous reporting period.
Although periodic circumstance commonly energize III. Quarter 2026 Revenue, this plainly could not be substantial to rescue Medical Equipment & Supplies's company achievement, Most analysts pointed out.
Within Medical Equipment & Supplies industry 31 other companies have achieved higher Revenue quarter on quarter growth. While Bausch And Lomb's Revenue growth quarter on quarter, overall rank is 737.
Bausch And Lomb's 12 Months Revenue Growth Year on Year
Although Bausch And Lomb's Annual Revenue growth year on year were below company's average 11.33% , Revenue announced in the Sep 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 8.88% year on year, from 8.85% in Jun 30 2026.
In the Healthcare sector 222 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1102 to 1228.
Although Bausch And Lomb's Annual Revenue growth year on year were below company's average 11.33% , Revenue announced in the Sep 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 8.88% year on year, from 8.85% in Jun 30 2026.
In the Healthcare sector 222 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1102 to 1228.
About Bausch And Lomb Revenue Growth Rates (BLCO), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
12.78%